Advanced search
Publication Cover
Leukemia & Lymphoma Volume 48, 2007 - Issue 5
Submit an article Journal homepage
110
Views
7
CrossRef citations to date
0
Altmetric
Letter to the Editor

Immuno-chemotherapy with a combination of rituximab, methotrexate, pirarubicin and procarbazine for patients with primary CNS lymphoma—A preliminary report

Ryuya Yamanaka Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan; Research Center of Innovative Cancer Therapy, Kurume University School of Medicine, Kurume, JapanCorrespondence[email protected]
, MD, PhD,
Junpei Homma Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan
,
Masakazu Sano Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan
,
Naoto Tsuchiya Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan
,
Naoki Yajima Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan
,
Yoshikatsu Shinbo Department of Neurosurgery, Itoigawa General Hospital, Itoigawa, Japan
,
Akira Hasegawa Department of Neurosurgery, Kobari Hospital, Niigata, Japan
,
Kiyoshi Onda Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan
&
Ryuichi Tanaka Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan
 show all
Pages 1019-1022 | Received 25 Oct 2006, Accepted 27 Jan 2007, Published online: 01 Jul 2009

References

  • DeAngelis L M, Yahalom J, Thaler H T, Kher U. Combined modality therapy for primary CNS lymphoma. J Clin Oncol 1992; 10: 635–643
  • Bessell E M, Graus F, Punt J A, Firth J L, Hope D T, Moloney A J, et al. Primary non-Hodgkin's lymphoma of the CNS treated with BVAM or CHOD/BVAM chemotherapy before radiotherapy. J Clin Oncol 1996; 14: 945–954
  • Yamanaka R, Tanaka R. Advances for the treatment of primary central nervous system lymphoma (review). Oncol Rep 2004; 12: 563–568
  • Abrey L E, DeAngelis L M, Yahalom J. Long-term survival in primary CNS lymphoma. J Clin Oncol 1998; 16: 859–863
  • Abrey L E, Yahalom J, DeAngelis L M. Treatment for primary CNS lymphoma: the next step. J Clin Oncol 2000; 18: 3144–3150
  • Freilich R J, Delattre J Y, Monjour A, DeAngelis L M. Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients. Neurology 1996; 46: 435–439
  • Yamanaka R, Morii K, Shinbo Y, Takeuchi S, Tamura T, Hondoh H, et al. Modified ProMACE-MOPP hybrid regimen with moderate dose methotrexate for patients with primary CNS lymphoma. Ann Hematol 2005; 84: 447–455
  • Aoki S, Tsukada N, Nomoto N, Maruyama S, Takahashi M, Moriyama Y, et al. Effect of pirarubicin for elderly patients with malignant lymphoma. J Exp Clin Cancer Res 1998; 17: 465–470
  • Enting R H, Demopoulos A, DeAngelis L M, Abrey L E. Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide. Neurology 2004; 63: 901–903
  • O'Brien P, Roos D, Pratt G, Liew K, Barton M, Poulsen M, et al. Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma. J Clin Oncol 2000; 18: 519–526
  • Sandor V, Stark-Vancs V, Pearson D, Nussenblat R, Whitcup S M, Brouwers P, et al. Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma. J Clin Oncol 1998; 16: 3000–3006
  • Schlegel U, Pels H, Glasmacher A, Kleinschmidt R, Schmidt-Wolf I, Helmstaedter C, et al. Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: a pilot study. J Neurol Neurosurg Psychiatry 2001; 71: 118–122
  • Neuwelt E A, Goldman D L, Dahlborg S A, Crossen J, Ramsey F, Roman-Goldstein S, et al. Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function. J Clin Oncol 1991; 9: 1580–1590
  • Pels H, Schmidt-Wolf I G, Glasmacher A, Schulz H, Engert A, Diehl V, et al. Primary central nervous system lymphoma: Results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy. J Clin Oncol 2003; 21: 4489–4495
  • Cher L, Glass J, Harsh G R, Hochberg F H. Therapy of primary CNS lymphoma with methotrexate-based chemotherapy and deferred radiotherapy: preliminary results. Neurology 1996; 46: 1757–1759

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.